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Efficacy of a Mycotoxin Binder against Dietary Fumonisin,
Deoxynivalenol, and Zearalenone in Rats
Zhiyi Qiang,† My Truong,‡ Koen Meynen,‡ Patricia A. Murphy,† and Suzanne Hendrich*,†
†Department of Food Science and Human Nutrition, 220 MacKay, Iowa State University, Ames, Iowa 50011, United States
‡Kemin Nutrisurance, 600 East Court Avenue #D, Des Moines, Iowa 50317, United States
ABSTRACT: It was hypothesized that a mycotoxin binder, Grainsure E, would inhibit adverse eﬀects of a mixture of fumonisin B1,
deoxynivalenol, and zearalenone in rats. For 14 and 28 days, 810 SpragueDawley rats were fed control diet, Grainsure E (0.5%),
toxins (7 μg fumonisin B1/g, 8 μg of deoxynivalenol/g and 0.2 μg of zearalenone/g), toxins (12 μg of fumonisin B1/g, 9 μg of
deoxynivalenol/g, and 0.2 μg of zearalenone/g + Grainsure E), or pair-fed to control for food intake of toxin-fed rats. After 28 days,
decreased body weight gain was prevented by Grainsure E in toxin-fed female rats, indicating partial protection against
deoxynivalenol and fumonisin B1. Two eﬀects of fumonisin B1 were partly prevented by Grainsure E in toxin-fed rats, increased
plasma alanine transaminase (ALT) and urinary sphinganine/sphingosine, but sphinganine/sphingosine increase was not prevented
in females at the latter time point. Grainsure E prevented some eﬀects of fumonisin B1 and deoxynivalenol in rats.
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’ INTRODUCTION
Mycotoxins are produced by fungi such as Aspergillus, Peni-
cillium, Fusarium, and Alternaria that contaminate at least 25% of
the world’s agricultural commodities.1 The content of mycotox-
ins varies, depending on storage, environmental, and ecological
conditions and temperature and moisture conditions in crops.
Deoxynivalenol or vomitoxin (Figure 1), derived from Fusarium
graminearum and Fusarium culmorum, is associated with Fusarium
head blight. Deoxynivalenol inhibits protein synthesis by binding to
ribosomes,2 and it suppresses peripheral blood leukocyte subsets,
inhibits lymphocyte proliferation, and induces pro-inﬂammatory
cytokine and chemokine expression in cell culture or animal models.
Fumonisin B1 (Figure 1), produced by Fusarium verticillioides and
Fusarium proliferatum, is neurotoxic, hepatotoxic, nephrotoxic, im-
munosuppressive, and carcinogenic in various animal species. Fu-
monisins inhibit the enzyme ceramide synthase (sphinganine/
sphingosine N-acyltransferase) and cause the accumulation of
sphingoid bases in blood and urine.3 A greater ratio of sphinga-
nine/sphingosine is a biomarker for fumonisin exposure in animal
models. Zearalenone, a nonsteroidal estrogenic mycotoxin isolated
from F. graminearum, is a potent estrogenic metabolite causing
infertility, abortion, or other breeding problems in swine
(Figure 1).4 Zearalenone and its metabolites resemble estradiol
and bind estrogen receptors, causingmammary cancer, fetal skeleton
anomalies, and uterotrophic and embryopathic activity. Several
combinations of mycotoxins frequently occur, such as the co-
occurrence of deoxynivalenol with zearalenone or of nivalenol or
aﬂatoxin B1 with ochratoxin A or other Fusarium toxins in cereal
grains, animal feeds, and forages.5
Several mycotoxin adsorbents prevented deoxynivalenol, fu-
monisin B1 (FB1), or zearalenone toxicity, including inorganic
binders, such as zeolites, bentonites, clays, and organic adsor-
bents such as glucomannan, cholestyramine, and pectin. Zeolite
and related clays partially prevented aﬂatoxin (2 mg/kg of bw)
induced maternal and developmental toxicities in rats.6 Cholestyra-
mine at 2% in thediet signiﬁcantly decreased sphinganine/sphingosine
in kidney and urine in rats fed fumonisins at 20 μg/g.7 A carbon/
aluminosilicate-based product (2%) signiﬁcantly decreased my-
cotoxin absorption, that is, 88% for aﬂatoxin B1, 44% for
zearalenone, and 29% for the fumonisins and ochratoxin, in an
in vitro gastrointestinal model.8 However, the toxicity of the mixture
of deoxynivalenol, fumonisin B1, and zearalenone in rats has not
been reported, nor have protective factors been identiﬁed against all
three toxins. Grainsure E is a product formulated with diﬀerent clay
minerals having mycotoxin adsorption capability, and it can be
altered by acid activation to increase speciﬁc surface area, porosity,
and surface acidity. A wide range of activated clay minerals were
tested in vitro for their mycotoxin binding eﬃcacy (diﬀerence
between the amount adsorbed and desorbed). On the basis of the
obtained results a combination of claymineralswas selected to obtain
a wide range of binding capacity, further supplemented with
butylated hydroxyanisole as a preservative to formulate Grainsure E.
The proposed action of the mycotoxin binder, Grainsure E, is that
mycotoxins that are adsorbed in the gut by the clay minerals in this
binder will not be taken up and will thus be less toxic to animals.
This study was conducted to test the hypothesis that a mycotoxin
binderwould decrease hepatoxicity, nephrotoxicity, and reproductive
toxicity over 14 and 28 days in SpragueDawley rats fed deoxyni-
valenol, fumonisin B1, and zearalenone. Plasma clinical chemistry,
urine sphingolipid concentrations, and organ morphology and
histopathology analyses were analyzed to assess the hypothesis.
’MATERIALS AND METHODS
Materials.Themycotoxin binder Grainsure E, a proprietary product
of a specific blend of components designed to bind fungal toxins, was
obtained fromKemin Europa N.V., Belgium. Zearalenone and standards
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of D-sphingosine, DL-erythro-dihydrosphingosine (sphinganine), O-
phthaldialdehyde, and 2-mercaptoethanol were obtained from Sigma-
Aldrich (St. Louis, MO); D-erythro-C20-dihydrosphingosine (internal
standard) was bought from Matreya LLC (Pleasant Gap, PA); CHCl3
and CH3OH (HPLC grade) were purchased from Fisher Scientific
(Pittsburgh, PA). F. verticillioides MRC 826 corn culture material (after
inoculation with 1020 beads of fumonisin spores, in modified Myro
medium (0.5 g/L of MgSO4) plus 1% corn-hull-extract incubated for 69
days) containing 9807 μg of FB1/g was obtained from the Veterinary
Medical Diagnostic Laboratory at the University of Missouri, Columbia,
MO.9 Rice culture infected with F. graminearum R6575 (containing
640 μg of deoxynivalenol/g and 57 μg of 15-acetyldeoxynivalenol/g),
after inoculation on potato dextrose agar plates and incubation in
carboxymethylcellulose media (composed of carboxymethylcellulose,
NH4NO3 3 7H2O, and yeast extract) mixed with enriched white rice, was
prepared previously by Dr. Hendrich’s laboratory according to the
method of Clifford et al.10
Diet. Rats were divided into five groups: control (fed AIN93G diet
obtained from Harlan Teklad, Madison, WI), Grainsure E (0.5% in AIN
93G), toxins (mixture of fumonisin B1, deoxynivalenol, and zearalenone
in AIN93G), toxins + Grainsure E, and pair-fed controls (fed daily the
mean food intake of toxin group as measured on the previous day). The
intended concentrations of toxins were 12 μg of deoxynivalenol/g, 8 μg
of fumonisin B1/g, and 0.5 μg of zearalenone/g, selected on the basis of
realistic values of natural contamination observed in cereals worldwide.5
Contaminated culture materials (4.2 g of culture containing 9807 μg of
FB1/g and 95.8 g of culture containing 640 μg of deoxynivalenol/g)
were mixed with 1100 mL of water and then further mixed with 5 kg of
AIN93G. Because zearalenone is insoluble in water, 2.55 mg of
zearalenone was dissolved in 5 mL of ethanol/5 kg of diet, mixed with
diet ingredients by a Hobart mixer; each diet, with or without Grainsure
E, was mixed for 20 min with the same amount of water (Hobart Corp.,
Troy, OH). After 12 days drying, each diet was cut into bars and stored
at 20 C until feeding. To check the homogeneity, three samples of
each diet were taken randomly and analyzed for mycotoxins by Eurofins
(DesMoines, IA) according to AOACmethods for the determination of
fumonisin B1, deoxynivalenol, and zearalenone in corn, cereal, and
maize products using HPLC.1113 The limit of detection was 100 ng/g
for fumonisin B1 and deoxynivalenol and 50 ng/g for zearalenone.
Control diets with and without Grainsure E contained no detectable
mycotoxins (deoxynivalenol, T-2 tetraol, Fusarenone-X, 3-acetyldeox-
ynivalenol, 15-acetyldeoxynivalenol, T-2 triol, T-2 toxin, isoT-2 toxin,
scirpentriol, nivalenol, 15-acetylscirpentriol, neosolaniol, HT-2 toxin,
acetyl T-2, zearalenol, zearalenone, and FB1). Final dietary toxin
concentrations were deoxynivalenol, 8.4 ( 0.8 μg/g in toxins diet or
8.8 ( 0.3 μg/g in toxins + Grainsure E diet; fumonisin B1, 7.3 ( 0.6
μg/g in toxins diet or 11.7 ( 0.8 μg/g in toxins + Grainsure E diet;
zearalenone, 0.2( 0.01μg/g in toxins diet or 0.2( 0.02 μg/g in toxins +
Grainsure E diet. The homogeneity of the mycotoxins in the diets was
satisfactory.
Animal Study Design. Animal use and related procedures were
approved by the Iowa State University Committee on Animal Care.
Eighty-four male (∼106 g) and female (∼93 g) SpragueDawley rats
(21 days old) were purchased fromHarlan Teklad (Madison, WI). After
adapting to the control diet for 2 weeks, rats were randomly assigned to
treatment diets so that mean initial body weights of the five groups were
similar. The positions of the animal cages were changed once weekly.
Rats were fed and food intake measured daily for 14 or 28 days. Forty
animals (8 animals from each group) were euthanized on day 15, and the
44 remaining animals (8 animals from control, Grainsure E, and pairfed
groups, and 10 animals from toxin and toxin + Grainsure E groups) were
euthanized on day 29 (feed was withheld overnight prior to necropsy).
All animals had free access to drinking water in a temperature-controlled
(23 C) room with a lightdark cycle of 12 h.
Animal Health and Organ Pathology. Animal health was
evaluated daily and body weight recorded weekly. Urine was collected
in a metabolic cage on day 14 or 28. Blood was collected by cardiac
puncture, heparinized, and centrifuged at 3000 rpm for 15 min to
prepare plasma that was stored at 60 C until analysis. Liver, kidney,
spleen, thymus, uterus, ovaries, and testes were collected, weighed, and
fixed in 10% buffered formalin for histopathological anaylsis. After a
week of fixation, tissues were trimmed, placed in cassettes, and subjected
to routine processing and staining with hematoxylin and eosin. Liver,
kidney, spleen, thymus, and testis or ovary, oviduct, and uterus were
examined by Dr. Ronald K. Myers, Iowa State University Veterinary
Pathology, board certified veterinary pathologist (without knowledge of
the identity of the groups).
Determination of Clinical Chemistry in Rat Plasma. Plasma
of each animal (500 μL) was tested by the Veterinary Pathology
Laboratory, Iowa State University, with two replicates. Clinical chemical
parameters including ion concentrations, blood urine nitrogen, creati-
nine, glucose, total protein, albumin, alkaline phosphatase (ALP), and
alanine transaminase (ALT) were compared among treatments. A
BoehringerMannheim/Hitachi 912 System (RocheDiagnostics GmbH,
Mannheim, Germany) was used, and end point assay was selected to
indicate the component concentration. All reagent kits were obtained
from Roche Diagnostics Corp. (Indianapolis, IN).
Determination of Sphingosine and Sphinganine in Rat
Urine. High-performance liquid chromatography (HPLC) analysis of
sphingosine and sphinganine was performed on a Varian instrument
with a 9300 automatic injector (Palo Alto, CA). The model 470
fluorescence detector was fromWaters Inc. (Milford, MA). The column
used was a 15 cm  4.6 mm i.d., 5 μm, Supelcosil ABZ+Plus (Sigma-
Aldrich, St. Louis, MO). Themobile phase was CH3OH/H2O (9:1, v/v)
and the flow rate was 1.5 mL/min. Two milliliters of urine from females
or 10 mL of urine from males (due to lesser concentration of
sphinganine and sphingosine in male urine) was extracted according
to a published method.14 D-Erythro-C20-dihydrosphingosine was used
as internal standard, and after extraction, samples were derivatized with
o-phthaldialdehyde for HPLC analysis using a fluorescence detector
(λex = 334 nm, λem = 440 nm). Standards were prepared by adding 1, 5,
10, 20, or 50 μL of 1 μM solutions of sphingosine and sphinganine, 10 μL
of 1 μM C20, and 100 μL of o-phthaldialdehyde to the mobile phase.
Samples were left for at least 0.5 h at room temperature after the addition
Figure 1. Mycotoxin structures.
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of o-phthaldialdehyde before injection to HPLC. Urine concentrations
of sphingosine and sphinganine were calculated by establishment of
calibration curves using the ratio of peak area of sphinganine or
sphingosine to peak area of internal standard.
Statistical Analysis.Data are given as the mean( SD. Differences
in body weights, food intakes, organs weights relative to the body
weights, clinical chemical parameters, and sphinganine and sphingosine
concentrations in urine among treatment groups were evaluated statis-
tically using a two-sample t test, ANOVA, and Tukey’s multiple-
comparison test by SAS 9.1. Differences were considered to be signi-
ficant at p < 0.05.
’RESULTS AND DISCUSSION
BodyWeight Gain and Food Intake. After 14 days, the body
weight gain was significantly less in rats fed toxins compared with
control, Grainsure E, and pair-fed groups (p = 0.036), but rats fed
toxin + Grainsure E did not differ compared with rats fed toxins
or control diets in both males and females (Table 1). After 28
days, pair-fed male rats or those fed with toxins and toxins +
Grainsure E showed significantly less body weight gain than
controls, and females fed toxins showed significantly less body
weight than controls (Table 1). No difference was seen in
females fed toxins + Grainsure E compared with controls. Food
intake was partly restored by Grainsure E in toxin-fed rats
because the intake of this group did not differ from controls or
toxin-fed rats after either time point in males or females.
The decreases of both body weight gain and food intake were
important signs of mycotoxicoses in rats.15 Food intake reduc-
tion can be due to the anorexic eﬀects of deoxynivalenol or the
toxic eﬀects of fumonisin B1.16 In our study, Grainsure E
protected body weight gain only in females fed toxins after 28
days, indicating a sex diﬀerence in the mechanism of action of
Grainsure E possibly related to interactions between the myco-
toxin binder and endogenous estrogens and/or zearalenone.
Organ Weight Measurement. The relative kidney weight in
toxin-fed males decreased 5.1% (p = 0.036) and thymus in-
creased 7.4% (p = 0.044) compared with controls after day 14
(Table 2), whereas differences were not seen in toxins +
Grainsure E fed males compared with control, Grainsure E, or
pair-fed males. After day 28, the relative kidney weight decreased
significantly in males fed toxins or toxins + Grainsure E com-
pared with control, Grainsure E, and pair-fed males, and males
fed toxins showed 5.9% less kidney weight than did males fed
toxins + Grainsure E (p = 0.041), indicating that Grainsure E
counteracted nephrotoxic effects of the mycotoxins. No differ-
ences were found between the relative kidney and thymus weight
in pair-fed and control males on day 15, but the relative thymus
weight was less in the other four groups compared with controls
on day 29. Because the relative liver or kidney weight was
decreased by fumonisin B1,16 not affected by deoxynivalenol,17
or increased by zearalenone,18 relative organ weight changes may
be complicated in indicating the combined effects of mycotoxins
with different mechanisms and target organs. The significant
effects of Grainsure E on the relative weights of spleen, testes, and
thymus only after day 28 needs more study. In female rats, it is
interesting that there were no significant differences in relative
organ weights among treatments for females, except for increases
of relative uterus and ovary weights in the other four groups
compared with controls after day 14. Heneweer et al.19 studied
different doses of zearalenone in rats and found that only 1 and
10 mg/kg bw (equivalent to 10 and 100 μg/g in diet)
significantly increased relative uterus weight compared with
controls, but not 0.03, 0.1, and 0.3 mg/kg bw (equivalent to
0.3, 1, and 3 μg/g in diet). The amount of zearalenone in our
study was 0.2 μg/g diet; therefore, zearalenone may not have
caused uterine hypertrophy in our study. The reason we saw
significantly greater weight of uterus and ovaries after day 14
might be related to some interaction between the treatments
and estrus, which begins at 67 weeks after birth; this would be
worth further investigation.
Determination of Clinical Chemistry in Rat Plasma. Grain-
sure E protected rats from nephrotoxicity and hepatoxicity as
shown by clinical chemical parameters. After day 14, females
fed toxins differed from controls in increased chloride by 2.2%
(p = 0.042) and decreased bicarbonate by 21.2% (p = 0.021,
Table 3). The concentrations of phosphorus, magnesium, and
ALP decreased, whereas chloride and glucose concentration
increased in males fed toxins compared with controls, which
were not seen in males fed toxins + Grainsure E. Similarly, the
above clinical parameters of females fed toxins + Grainsure E did
not differ compared with those of controls after day 14.
Table 1. Comparison of Body Weight Gain and Food Intake of Diﬀerent Groups after 14 and 28 Days of Feeding a
14 days 28 days
treatment male female male female
Body Weight Gain (g)
control 75.5 ( 6.7 a 41.3( 4.1 a 160.1( 14.0 a 80.3( 5.5 a
Grainsure E 81.1( 3.2 a 41.8( 5.2 a 127.7( 5.9 ab 85.1( 11.2 a
toxins 61.3( 4.5 b 37.7( 1.6 b 120.0( 12.2 b 58.1( 4.9 b
toxins + Grainsure E 64.7( 12.3 ab 41.3( 8.0 ab 120.7( 10.5 b 78.0( 6.1 a
pair-fed b 78.3 ( 2.1 a 40.1( 1.7 a 123.7( 18.5 b 75.1( 5.9 a
Food Intake (g)
control 150.0( 28.4 a 137.7( 14.6 a 397.4( 52.8 a 403.7( 38.6 a
Grainsure E 144.7( 31.6 a 126.7 ( 38.6 a 403.7( 73.5 a 384.7 ( 87.5 a
toxins 87.3( 16.2 b 93.3( 17.6 b 248.3( 50.2 b 275.3( 59.5 b
toxins + Grainsure E 98.6( 28.0 ab 98.0( 21.0 ab 277.7( 59.5 ab 310.3( 70.1 ab
aDiﬀerent letters in a column indicate signiﬁcant diﬀerences (p < 0.05). bThe food intake of the pair-fed group was given according to the average
amount consumed by the animals in the toxin-fed group 1 day before.
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Previous studies showed increased serum chloride in rats given
0.251.0 mg/kg bw deoxynivalenol (2.510 μg/g in diet),17
and lower serum calcium and phosphorus in pigs fed 10 μg of
deoxynivalenol/g in diet compared with controls,20 but elevated
serum calcium and magnesium were found in rats fed fumonisin
B1 (7.5 μg/g), whereas serum chloride, phosphate, and ALP
were not altered by fumonisin B1.16 In our experiment, signiﬁ-
cant increases of serum chloride and decreases of serum phos-
phorus and magnesium were found in rats fed the mixture of
three mycotoxins, which may be a sign of nephrotoxicity, because
Table 2. Comparison of Relative Organ Weighta of Diﬀerent Groups after 14 and 28 Days of Feedingb
male female
treatment no. per group kidney (%) liver (%) spleen (%) testes (%) thymus (%) uterus and ovaries (%)
Day 14
control 8 0.968 ( 0.026 a 4.570( 0.250 a 0.307( 0.024 a 1.341( 0.111 a 0.406( 0.017 a 0.307( 0.046 b
Grainsure E 8 1.066 ( 0.043 a 4.496( 0.086 a 0.313( 0.033 a 1.389( 0.086 a 0.377( 0.065 a 0.371( 0.108 a
toxins 9 0.919 ( 0.066 b 4.476( 0.697 a 0.284( 0.023 a 1.467( 0.092 a 0.436( 0.004 b 0.449( 0.071 a
toxins + Grainsure E 9 0.980 ( 0.033 a 4.348( 0.251 a 0.305( 0.006 a 1.357( 0.118 a 0.421( 0.023 a 0.468( 0.026 a
pair-fed 8 0.984 ( 0.047 a 4.451( 0.489 a 0.299( 0.056 a 1.353( 0.063 a 0.422( 0.040 a 0.509( 0.063 a
Day 28
control 8 0.867 ( 0.055 A 3.816( 0.380AB 0.243( 0.013 A 1.166( 0.065C 0.372( 0.045 A 0.382( 0.063 A
Grainsure E 8 0.917 ( 0.055 A 3.714( 0.186 BC 0.220( 0.023 B 1.239( 0.108 B 0.284( 0.033C 0.393( 0.240 A
toxins 9 0.754 ( 0.027 C 3.613( 0.284 BC 0.235( 0.020 AB 1.370( 0.138 A 0.325( 0.039 B 0.395( 0.153 A
toxins + Grainsure E 9 0.801 ( 0.012 B 3.366( 0.406C 0.232( 0.010 AB 1.367( 0.105 A 0.311( 0.034 BC 0.369( 0.045 A
pair-fed 8 0.959 ( 0.079 A 4.239( 0.692A 0.273( 0.042 A 1.406( 0.159 A 0.353( 0.045 B 0.399( 0.133 A
aThe weight of every organ was relative to the body weight of each animal (%). bDiﬀerent letters in individual columns indicate signiﬁcant diﬀerences at
the same time point (lower case letter for day 14 and capital letter for day 28, p < 0.05).
Table 3. Clinical Chemistry across Treatment Groups after 14 and 28 Days of Feedinga
treatment
chloride
(mequiv/L)
bicarbonate
(mequiv/L)
calcium
(mg/dL)
phosphorus
(mg/dL)
magnesium
(mg/dL)
creatinine
(mg/dL)
glucose
(mg/dL)
ALPb
(IU/L)
ALTc
(IU/L)
Day 14
control (Md) 99.4( 1.1 b 23.5( 4.3 a 12.7( 0.5 a 18.6( 2.1 a 4.3( 0.5 a 0.4( 0.0 b 35.5( 20.5 b 181.5( 11.4 a 51.0( 14.3 a
Grainsure E (M) 97.6( 1.3 b 26.1( 3.1 a 12.6( 0.2 a 17.6( 1.8 ab 4.5( 0.4 a 0.4( 0.0 b 30.2 ( 14.1 b 189.0( 2.3 a 61.0 ( 7.3 a
toxins (M) 102.5 ( 1.2 a 26.6( 3.3 a 12.6( 0.6 a 14.6( 1.8 b 3.4( 0.3 b 0.4( 0.0 b 60.2( 13.5 a 157.0( 9.8 b 55.0( 12.5 a
toxins + Grainsure E (M) 101.4( 2.8 ab 27.3( 6.3 a 13.6( 1 a 15.4( 1.8 ab 3.8( 0.7 ab 0.5( 0.0 a 35.5( 58.1 b 177.5 ( 16.8 a 74.0( 22.9 a
pair-fed (M) 99.2( 1.2 b 26.6( 3.0 a 12.7( 0.4 a 15.6( 1.9 ab 3.9( 0.2 a 0.4( 0.1 b 46.3( 8.5 b 171.5( 7.1 a 67.5( 10.6 a
control (F) 101.5( 2.8 B 27.7( 2.3 A 12.1( 0.2 A 16.6( 2.2 AB 4.2( 5.0 A 0.4( 0.0 A 52.7 ( 14.4 A 114.2( 19.6 A 44.5 ( 6.2 A
Grainsure E (F) 103.9( 1.6 AB 23.0( 5.5 AB 12.0( 0.4 A 15.8( 0.8 A 4.2 ( 0.2 A 0.4( 0.0 A 81.7( 52.1 A 111.0( 19.2 A 42.5( 17.9 A
toxins (F) 106.7( 1.7 A 21.9( 1.9 B 12.1( 0.6 A 13.6( 1.4 B 3.4( 0.7 A 0.3( 0.1 A 57.7( 9.2 A 113.5( 19.3 A 52.0( 7.7 A
toxins + Grainsure E (F) 103.8( 1.0 AB 24.6( 2.4 AB 12.2( 0.5 A 15.3( 1.3 AB 3.7( 0.5 A 0.3 ( 0.0 A 68.5( 17.1A 126.5( 10.9 A 40.7( 2.6 A
pair-fed (F) 102.0( 2.4 AB 27.0( 3.8 AB 12.3( 0.4 A 14.2( 1.2 AB 4.1( 0.6 A 0.3( 0.0 A 51.7( 7.3 A 91.5( 17.4 B 41.0( 4.7 A
Day 28
control (M) 97.2( 1.6 b 37.2( 1.8 a 12.3( 0.2 a 15.9( 1.0 a 3.7( 0.3 a 0.3 ( 0.1 a 44.2( 17.0 b 117.5 ( 11.1 b 33.5( 4.4 b
Grainsure E (M) 99.4( 1.7 b 32.8 ( 2.5 a 12.2( 0.5 a 16.3( 1.6 a 3.9( 0.4 a 0.4( 0.1 a 65.6( 41.8 b 131.0( 9.3 a 30.5( 1.7 b
toxins (M) 101.1( 2.3 a 30.7( 4.8 b 12.2( 0.6 a 14.4( 0.7 b 3.7( 0.5 a 0.4( 0.1 a 88.5( 38.9 a 123.2( 9.9 a 65.2( 20.2 a
toxins + Grainsure E (M) 98.8( 1.6 b 35.3( 2.2 a 12.3( 0.7 a 15.0( 2.1 a 3.3( 0.4 a 0.3( 0.1 a 72.0( 30.6 b 116.0( 12.2 b 33.4( 3.1 b
pair-fed (M) 99.8( 3.0 b 34.2( 2.7 a 12.2 ( 0.3 a 14.1( 1.2 b 3.6( 0.1 a 0.4( 0.1 a 62.5( 50.7 b 111.5( 19.5 b 33.7( 3.6 b
control (F) 96.4( 1.2 A 33.9( 4.7 A 12.2( 0.1 A 15.3 ( 2.3 A 3.6( 0.1 A 0.4( 0.1 A 43.5( 21.1 B 83.2( 13.8 A 29.0( 3.3 B
Grainsure E (F) 99.3( 1.5 A 36.2( 1.4 A 12.3( 0.2 A 15.4( 0.9 A 3.6( 0.1 A 0.4( 0.0 A 63.0( 8.1 B 90.0( 11.6 A 30.0( 5.0 B
toxins (F) 100.7( 1.1 A 34.8( 2.7 A 11.8( 0.2 B 12.4( 0.8 B 3.4 ( 0.1 A 0.4( 0.1 A 70.0( 23.9 A 89.6( 19.4 A 40.2( 7.7 A
toxins + Grainsure E (F) 101.6( 2.4 A 32.3( 3.6 A 11.6( 0.3 B 11.7( 0.6 B 3.3 ( 0.4 A 0.4( 0.1 A 50.8( 26.8 B 85.2( 6.9 A 31.4( 10.8 B
pair-fed (F) 98.3( 1.5 A 30.0( 1.1 B 12.5( 0.2 A 15.7( 1.4 A 3.9( 0.2 B 0.4( 0.1 A 60.5( 34.9 B 89.7( 17.5 A 27.3( 10.3 B
aDiﬀerent letters in individual columns indicate signiﬁcant diﬀerence for diﬀerent sex (lower case letter for male and capital letter for female, p < 0.05).
bALP, alkaline phosphatase. cALT, alanine transaminase. dM, male; F, female; 8 animals per sex in control, Grainsure E, and pair-fed groups, and 9
animals per sex in toxin and toxin + Grainsure E groups.
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the concentrations of these ions in serum depend partly on the
rate of renal excretion.21
After day 28, the concentrations of chloride and ALP increased
in males fed toxins, but bicarbonate and phosphorus decreased
compared with controls, whereas these changes did not occur in
males fed toxins + Grainsure E. Phosphorus was also signiﬁcantly
decreased in pair-fed male rats, with no signiﬁcant diﬀerences
between pair-fed and toxin-fed males. This implies that the
change of phosphorus was not due to toxins but to lesser food
intake. Calcium and phosphorus both decreased in females fed
toxins and toxins + Grainsure E. More interestingly, glucose was
signiﬁcantly elevated in toxin -fed animals but not in rats fed
toxins + Grainsure E compared with controls. Deoxynivalenol
increased blood insulin, glucose, and free fatty acid after sub-
cutaneous treatment at 1 mg/kg bw (10 μg/g in diet) in rats for 3
days, which might be due to harmful eﬀects of deoxynivalenol on
the pancreas.22 Therefore, Grainsure E acted against nephro-
toxicity in terms of ion absorption and excretion as well as
glucose elevation, probably induced by deoxynivalenol and
fumonisin B1, and Grainsure E alone has no adverse eﬀects on
chloride, bicarbonate, calcium, phosphorus, and magnesium in
either males or females, further indicating the protection of
Grainsure E without aﬀecting utilization and metabolism of
essential minerals.
Grainsure E counteracted increased plasma ALT in toxin-fed
male and female rats after day 28. ALT in males and females fed
toxins increased by 95% (p = 0.018) and 39% (p = 0.031), but not
in rats fed toxins + Grainsure E (Table 3). The increase of ALT,
an indicator of hepatotoxicity, was also shown in fumonisin B1-16
or zearalenone-treated rats,23 although at much greater zearale-
none doses than in our study (>20 μg/g of diet). Although
deoxynivalenol is a protein synthesis inhibitor, no signiﬁcant
changes of the concentrations of cholesterol or protein were
found between toxin-fed and control groups. This might be
because fumonisin B1 induced increased serum total protein and
cholesterol,16 whereas deoxynivalenol suppressed protein or
cholesterol synthesis in mice.24
Sphingosine and Sphinganine in Rat Urine. Fumonisin B1
inhibits ceramide synthase, resulting in an interruption of de
novo sphingolipid synthesis. Sphinganine or sphinganine/sphin-
gosine was elevated in kidney and urine of rats fed fumonisin
B1.25 In our study, urinary concentrations of sphingosine and
sphinganine and sphinganine/sphingosine did not differ signifi-
cantly among males and females fed control, Grainsure E, and
pair-fed diets. Sphinganine/sphingosine significantly increased
by ∼11-fold for males and by ∼10-fold for females fed toxins
(p = 0.007) compared with controls on day 14 (Figure 2), but
male rats fed toxins +Grainsure E had less of an increase in sphin-
ganine/sphingosine than those fed toxins alone (p = 0.031) on
both days 14 and 28, whereas this was observed only at day 14 for
females.
Grainsure E concentration (0.5%) was seemingly insuﬃcient
to protect against the toxic eﬀects of fumonisin B1 when fed to
female rats for the longer time. Females have been shown to be
more sensitive than males to fumonisin B1 hepatoxicity and
males more sensitive than females to fumonisin B1 nephro-
toxicity.26 The eﬀect of fumonisin B1 on sphingolipids may be
more indicative of hepatotoxicity, which might explain the lesser
eﬃcacy of Grainsure E in females according to this measure.
Neither glucomannan nor activated carbon was eﬀective in
mitigating eﬀects of a mycotoxin mixture containing fumonisin
B127 or fumonisin B1 alone25 on sphingolipids. Grainsure E was
at least partly protective in both males and females in preventing
the inhibition of sphingolipid biosynthesis by fumonisin B1.
Histopathological Analysis of Organs.No consistent trends
or important differences of size, amount, and location of cyto-
plasmic vacuoles in liver were noted across the groups or between
sexes. No convincing morphologic evidence of hepatocellular
toxic injury was found. However, after day 28, toxin-fed males
(4 of 5 animals) had mild degenerative changes of kidney epithelial
cells (hyaline/pyknotic cells in tubules with basophilic tubular
clumps). This indicates that the kidney damage was mainly due
to fumonisin B1 toxicity. This change was not seen in males fed
toxins + Grainsure E after day 28, correlated with the finding that
kidney weight was partly protected by Grainsure E after day 28
(Table 2). In spleen, all treatments showed normal extramedul-
lary hematopoiesis, normal-appearing white and red pulp with
normal periarteriolar lymphocytes at both times. Uteri of some
rats had vacuoles and apoptotic cells in the endometrium and
upper lamina propria, but the changes were present in all groups
and were likely due to estrus, paralleled with the findings of
greater relative weight of uterus and overies (Table 2). All testes
appeared similar with variable but normal numbers of supporting
cells, development stages, and mature spermatids within semi-
niferous tubules of the same tissue. No discernible differences
were present among the thymuses; thus, the relative thymus
weight differences were likely incidental (Table 2).
Several studies showed histopathological changes in mycotox-
in-treated rats. Morsy et al.28 reported that after treating rats with
fumonisin (100 μg/g diet) for 1 month, vacuolar degeneration in
the epithelial cells of the renal tubules, hyaline casts scattered in
the tubular lumina, and pyknotic nuclei were noticed. Hepato-
cyte death due to necrosis and apoptosis with swollen mitochon-
dria and disintegrated cristae were consistently reported when
rats were exposed to 50250 μg of FB1/g of diet.16 Male rats
treated with 5 μg of deoxynivalenol/g of bw (∼50 μg/g in diet)
for 28 days showed glandular stomach and pancreatic lesions,
thymic lymphoid depletion, germ cell degeneration, and failure
of sperm release.15 However, the toxicity was less severe when
rats received less fumonisin B1 (10 or 1 μg/g of diet) for 24
months compared with a higher dose (25 μg/g of diet).26
Figure 2. Ratio of free sphinganine/sphingosine in urine of male and
female rats on days 14 and 28. $ and / are representative of signiﬁcant
diﬀerences compared with control and toxin groups, respectively (p <
0.05). Each bar represents the mean( SD (8 animals per sex in control,
Grainsure E, and pair-fed groups, and 9 animals per sex in groups fed
toxins).
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Therefore, the observation of discernible histopathological and
morphological diﬀerences depends on the doses of mycoto-
xins.29
In our study, no other diﬀerences between groups were seen
in livers, thymuses, spleens, testes, ovaries, oviducts, and uteri,
which might be due to the relatively low doses of fumonisin
B1 (711 μg/g), deoxynivalenol (8 μg/g), and zearalenone
(0.2 μg/g) fed.
In conclusion, Grainsure E prevented the mycotoxin
(fumonisin B1 and deoxynivalenol) induced loss of body weight
gain and food intake, hepatotoxicity, and nephrotoxicity in terms
of decreased relative kidney weight, increased plasma ALT,
elevated urinary sphinganine/sphingosine, and damaged kidney
morphology, which supported partial protective eﬀects of Grain-
sure E against these mycotoxins in rat. No evidence of reduced
toxicity was found for zearalenone, which was probably due to
the low dietary content of zearalenone. To our knowledge, the
interactive eﬀects of the mixture of deoxynivalenol, zearalenone,
and fumonisin B1 have been studied in one other paper and only
in vitro. Fumonisin B1 displayed antiestradiol properties that
antagonized eﬀects of zearalenone. Addition of deoxynivalenol to
zearalenone and fumonisin B1 was more eﬀective in reduction of
human colon cancer cell (Caco-2) viability and the apparent anti-
estradiol eﬀect of fumonisin B1 was less evident. The combina-
tion of the three toxins was not more eﬀective in lipid peroxida-
tion or in inhibitingDNA synthesis andmethylation as compared
to individual toxins, but the toxin combination wasmore eﬀective
than individual toxins in damaging DNA, suggesting an impor-
tant aspect for further study.30 We did not investigate the
individual toxins in our study; antagonistic, additive, or synergis-
tic eﬀects of the combination of three toxins are possible. In light
of these results, Grainsure E may be beneﬁcial in reducing
adverse eﬀects of fumonisin B1 and deoxynivalenol in animals.
Future research might focus on the study of immune responses
and hormone status corresponding to deoxynivalenol and zear-
alenone. Additional end points, such as metabolites correspond-
ing to the dysfunction of target organs of the toxins, should be
included and analyzed. Ultrastructural analysis or morpho-
metrics could also be utilized for further detailed histopathology.
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